The Ahlqvist Subphenotypes of Type 2 Diabetes: A Narrative Review of Scientific Evidence and Its Potential Contribution to Precision Diabetes
Open Access
- 5 October 2026
- journal article
- review article
- Published by Wiley in Diabetes, Obesity and Metabolism
Abstract
Background: Among several approaches, k‐means clustering has established as a widely used method to classify people with type 2 diabetes (T2D) into distinct subphenotypes, and the Ahlqvist T2D subphenotypes of Severe Insulin Deficient Diabetes (SIDD), Mild Age‐Related Diabetes (MARD), Mild Obesity Diabetes (MOD) and Severe Insulin Resistant Diabetes (SIRD) became the most replicated ones in diabetes cohorts since its introduction in 2018. This review summarises the current evidence gained from the Ahlqvist subphenotypes focusing on distribution patterns, key characteristics, comorbidities and their clinical implementation. Methods: We conducted a narrative literature search of PubMed for English‐language articles published from inception to June 2026 using combinations of the terms ‘k‐means clustering’, ‘classification of diabetes’, ‘ Ahlqvist methodology’, ‘type 2 diabetes’, ‘diabetes subphenotypes’ and ‘diabetes subtypes’. Literature was eligible which reported the same Ahlqvist classification method as originally applied. Results: Twenty‐eight cohorts were identified incorporating more than 97 000 people with diabetes. Ahlqvist subphenotypes have been studied mainly in White/European and East/South Asian populations but seldom in Black/Africans and Hispanic/Latin Americans. MARD and MOD had the highest prevalences among populations; SIDD had severe insulin deficiency and hyperglycaemia, and low fasting C‐peptide (FCP) levels; SIRD was insulin resistant with high FCP levels and incidence risk of nephropathy. Retrospective analyses of glycaemic responses to glucose‐lowering treatments did not clearly favour any drug regimen for subphenotypes. Conclusions: Ahlqvist T2D subphenotypes reflect the heterogeneity of T2D. However, clinical implementation is associated with many barriers, and further studies must prove the value of subphenotype‐guided management of T2D towards precision diabetes.Keywords
This publication has 42 references indexed in Scilit:
- A web-based application for diabetes subtyping: The DDZ Diabetes-Cluster-ToolActa Diabetologica, 2025
- Identifying subtypes of type 2 diabetes mellitus based on real-world electronic medical record data in ChinaDiabetes Research and Clinical Practice, 2024
- Clinical application of cluster analysis in patients with newly diagnosed type 2 diabetesHormones, 2024
- Responses to Basal Insulin Glargine (300 U/mL and 100 U/mL) with or Without Pre-prandial Insulin in Pre-treated Subphenotypes of Type 2 Diabetes: Insights from a Post Hoc AnalysisDiabetes Therapy, 2024
- Distribution and characteristics of newly-defined subgroups of type 2 diabetes in randomised clinical trials: Post hoc cluster assignment analysis of over 12,000 study participantsDiabetes Research and Clinical Practice, 2022
- The efficacy of canagliflozin in diabetes subgroups stratified by data-driven clustering or a supervised machine learning method: a post hoc analysis of canagliflozin clinical trial dataDiabetologia, 2022
- Subgroups of patients with young-onset type 2 diabetes in India reveal insulin deficiency as a major driverDiabetologia, 2021
- Validation of the classification for type 2 diabetes into five subgroups: a report from the ORIGIN trialDiabetologia, 2021
- Application of new international classification of adult‐onset diabetes in Chinese inpatients with diabetes mellitusDiabetes/Metabolism Research and Reviews, 2020
- Beneficial impact of intensified multifactorial intervention on risk of stroke: outcome of 21 years of follow-up in the randomised Steno-2 StudyDiabetologia, 2019